Open Access Open Access  Restricted Access Subscription or Fee Access

Sjogren’s Syndrome and Oral Care – A Review

S. Lavanya


Sjögren’s syndrome (SS) is a complex autoimmune disease characterized by a broad spectrum of clinical and serological manifestations. Patients with SS experience immune-mediated destruction of salivary and lacrimal glands leading to reduced lacrimal and salivary flow. Dry eyes and dry mouth together with fatigue are among the most common complaints. Extraglandular manifestations, such as involvement of the peripheral nervous, pulmonary, or gastrointestinal system, kidney, skin, myalgias, and arthralgias, are frequently seen leading to reduced quality of life. A range of autoantibodies can be present in SS such as anti-SSA/Ro (SS autoantigen A) and anti-SSB/La (SS autoantigen B) antibodies, rheumatoid factor, cryoglobulins, and antinuclear antibodies. Patients with primary SS also have an increased risk of B cell lymphomas. The predominant effects of SS on the oral cavity are mainly consequent to hypo salivation. Recent evidence reveals that over half of the patients with PSS experienced an oral symptom as their first manifestation of the condition. Lack of saliva causes difficulties in oral function.

Full Text:



. R. Jonsson, et al. Sjögren’s syndrome – a plethora of clinical and immunological phenotypes with a complex genetic background, Ann NY Acad Sci. 2007; 1108: 433–47p. doi: 10.1196/annals.1422.046.

. K. Haldorsen, et al. A five-year prospective study of fatigue in primary Sjögren’s syndrome, Arthritis Res Ther. 2011; 13(5): R167p. doi: 10.1186/ar3487.

. M. Ramos-Casals, et al. Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS task force recommendations for articular cutaneous pulmonary and renal involvements, Rheumatology (Oxford). 2015; 54(12): 2230–3p.

. E. Theander, et al. Lymphoma and other malignancies in primary Sjögren’s syndrome: a cohort study on cancer incidence and lymphoma predictors, Ann Rheum Dis. 2006; 65(6): 796–803p. doi: 10.1136/ard.2005.041186.

. M. Ramos-Casals, et al. Treatment of primary Sjögren syndrome: a systematic review, JAMA. 2010; 304(4): 452–60p. doi: 10.1001/jama.2010.1014.

. D.T. Zero, et al. Clinical practice guidelines for oral management of Sjögren disease: dental caries prevention, J Am Dent Assoc. 2016; 147(4): 295–305p. doi: 10.1016/j.adaj.2015.11.008.

. C. Scully. Medical Problems in Dentistry. 6th Edn. Edinburgh: Elsevier Health Sciences; 2010.

. P.C. Fox, S.J. Bowman, B. Segal, et al. Oral involvement in primary Sjögren syndrome, J Am Dent Assoc. 2008; 139: 1592–601p.

. R. Antoniazzi, L.A. Miranda, F.B. Zanatta, et al. Periodontal conditions of individuals with Sjögren's syndrome, J Peridontol. 2009; 80: 429–35p.

. G.A. Scardina, A. Ruggieri, P. Messina. Periodontal disease and Sjögren syndrome; a possible correlation? Angiology. 2009; 61: 289–93p.

. B. Kuru, M.J. McCullough, S. Yilmaz, S.R. Porter. Clinical and microbiological studies of periodontal disease in Sjögren syndrome patients, J Clin Periodontol. 2002; 29: 92–102p.

. B.T. Kurien, S.A. Mathews, R.H. Scofield. Can low dose diagnostic dental radiation trigger Sjögren's Syndrome? Med Hypotheses. 2007; 69(5): 995–1000p.

. S.S. Kassan, T.L. Thomas, H.M. Moutsopoulos, et al. Increased risk of lymphoma in sicca syndrome, Ann Intern Med. 1978; 89: 888–92p.

. M. Turner, L. Jahangiri, J.A. Ship. Hyposalivation, xerostomia and the complete denture: a systematic review, J Am Dent Assoc. 2008; 139: 146–50p.

. D.L. Cartee, et al. Sjögren’s syndrome: oral manifestations and treatment a dental perspective, J Dent Hyg. 2015; 89(6): 365–71p.


  • There are currently no refbacks.